The effect of intravitreal triamcinolone on diabetic macular oedema

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 5, 2005, Pages 478-481

  Krepler, Katharina ^a   Wagner, Julia ^a   Sacu, Stefan ^a   Wedrich, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; DEXAGENTA POS; DEXAMETHASONE; GENTAMICIN; POVIDONE IODINE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA EDEMA; SHORT COURSE THERAPY; SINGLE DRUG DOSE; SLIT LAMP; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 20444497910     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-1059-8     Document Type: Article

References (10)

1. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystic macular edema: An optical coherence tomography study. Ophthalmology 108:765-772 10.1016/ S0161-6420(00)00658-8
2. Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema: Early treatment diabetic retinopathy study. Report number 1. Arch Ophthalmol 103:1796-1806
3. Fong DS, Ferris FL III, Davis MD, Chew EY (1999) Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol 127:137-141 10.1016/S0002-9394(98)00309-2
4. Jonas JB, Kreissig I, Söfker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61 1:CAS:528:DC%2BD3sXps1KqsQ%3D%3D
5. Jonas JB, Akkoyun I, Kamppeter, Kreissig I, Degenring RF (2004) Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye:1-7 (advance online publication Apr 23)
6. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801-1815 10.1016/ S0161-6420(98)91020-X
7. Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 98:1594-1602 1:STN:280:By2D2szhs1c%3D
8. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927 10.1016/S0161-6420(02)00975-2
9. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 111:218-225 10.1016/ j.ophtha.2003.05.037
10. Park CH, Jaffe GJ, Fekrat S (2003) Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136:419-425 10.1016/S0002-9394(03)00228-9